Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Endocrinology and Metabolism (Seoul, Korea)|June 28, 2018
Latent Autoimmune Diabetes in Adults: Current Status and New HorizonsPaolo Pozzilli, Silvia Pieralice
Diabetes & Metabolism Journal|December 20, 2018
Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and ManagementSilvia Pieralice, Paolo Pozzilli
Journal of Clinical Medicine|May 13, 2023
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total PancreatectomySilvia Pieralice, Alessandro Coppola, Ernesto Maddaloni
Current Diabetes Reports|May 24, 2020
Correction to: "H" for Heterogeneity in the Algorithm for Type 2 Diabetes ManagementSilvia Pieralice, Simona Zampetti, Ernesto Maddaloni, et al.
Current Diabetes Reports|August 20, 2018
Lifestyle Management of Diabetes: Implications for the Bone-Vascular AxisSilvia Pieralice, Francesca Vigevano, Rossella Del Toro, et al.
Bioengineering (Basel, Switzerland)|June 2, 2021
Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning TechniquesBenedetta De Paoli, Federico D'Antoni, Mario Merone, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2020
The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging TreatmentsIlaria Cavallari, Ernesto Maddaloni, Silvia Pieralice, et al.
Endocrine|April 6, 2019
Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathySilvia Pieralice, Riccardo Vari, Alessandra Minutolo, et al.
Clinical Therapeutics|July 4, 2024
No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational StudySara Bodini, Silvia Pieralice, Luca D'Onofrio, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 28, 2025
The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseSilvia Pieralice, Rocco Amendolara, Valentina Berna, et al.
Pageof 2